Recent Posts
- Blood Cancer Awareness Month is an opportunity to #kNOwMyeloma
- FDA declines linvoseltamab decision for RRMM due to facility issue
- Phase 3 trial of CAR T-cell therapy anito-cel for RRMM opens
- First-line induction therapy with Sarclisa delays myeloma progression
- FDA adds Darzalex Faspro to combo therapy for newly diagnosed MM